Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening

被引:1
|
作者
Carlsson, Sigrid, V [1 ,2 ,3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[3] Univ Gothenburg, Inst Clin Sci, Dept Urol, Sahlgrenska Acad, Gothenburg, Sweden
基金
美国国家卫生研究院;
关键词
Prostate cancer; Prostate specific antigen; Screening; Magnetic resonance imaging; Early detection;
D O I
10.1016/j.urolonc.2022.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:76 / 77
页数:2
相关论文
共 50 条
  • [41] PSA-based, prostate cancer risk on-line calculators: no such thing as a crystal ball?
    Lippi, Giuseppe
    Mattiuzzi, Camilla
    Plebani, Mario
    DIAGNOSIS, 2018, 5 (04) : 253 - 255
  • [42] Morphologic changes in prostate cancer samples following intraprostatic PSA-based vaccine administration
    Val, D.
    Gulley, J. L.
    Pinto, P.
    Schlom, J.
    Linehan, W. M.
    Merino, M. J.
    LABORATORY INVESTIGATION, 2007, 87 : 181A - 181A
  • [43] PSA-based parameters and their diagnostic performances in patients with prostate cancer and benign prostatic hyperplasia
    Kocer, Derya
    Karakukcu, Cigdem
    Karaman, Hatice
    Tasdemir, Arzu
    Ergul, Mehmet Ali
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2013, 38 (01): : 37 - 42
  • [44] Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer
    Meidenbauer, N
    Harris, DT
    Spitler, LE
    Whiteside, TL
    PROSTATE, 2000, 43 (02): : 88 - 100
  • [45] A systematic review of family history, race/ethnicity, and genetic risk on prostate cancer detection and outcomes: Considerations in PSA-based screening
    Graham, Nathan J.
    Souter, Lesley H.
    Salami, Simpa S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (01) : 29 - 40
  • [46] Changing Incidence and Stage Distribution of Prostate Cancer in a Lithuanian Population-Evidence from National PSA-Based Screening Program
    Patasius, Ausvydas
    Smailyte, Giedre
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (23)
  • [47] Patient selection for prostate biopsy: Risk-based or PSA-based?
    Nariculam, J.
    Shabbir, M.
    Thomas, Karen
    Le Roux, P. J.
    Walker, R. M.
    Charig, C. R.
    Parker, C.
    JOURNAL OF CLINICAL UROLOGY, 2012, 5 (03) : 128 - 133
  • [48] PSA screening for prostate cancer
    Wilt, Timothy J.
    Dahm, Philipp
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [49] PSA screening for prostate cancer
    Sadi, Marcus V.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (08): : 722 - 725
  • [50] PSA-based treatment response criteria in castration-resistant prostate cancer: promises and limitations
    Emmenegger, Urban
    Ko, Yoo-Joung
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (05): : 375 - 376